Ensysce Biosciences (ENSC) Revenue (2020 - 2025)
Ensysce Biosciences' Revenue came in at $493,104 for Q3 2025, down 85.6% from $3.42 million a year earlier and down 64.0% from the prior quarter.
Powered by 
Analysis
Ensysce Biosciences (ENSC) Revenue (2020 - 2025) Analysis & Trends
Over the trailing twelve months to Sep 30, 2025, Ensysce Biosciences reported Revenue of $4.49 million, up 1.5% year-over-year; for FY2024, it came in at $5.21 million, up 133.6% from FY2023.
- Revenue carries a four-year compound annual growth rate of 7.3% (FY2020 to FY2024).
- Going back by year, Revenue was $2.23 million in FY2023 (-11.6%), $2.52 million in FY2022 (-28.5%), $3.53 million in FY2021 (-10.2%) and $3.93 million in FY2020.
- The Q3 2025 figure represents the lowest quarterly Revenue since Q2 2024.
- Year-over-year, Revenue increased in four of the last eight quarters, with growth averaging 193.8%.
- The fastest year-over-year change in Revenue over five years came in Q3 2024 (growth of 685.3%), and the weakest in Q3 2025 (a decline of 85.6%).
- Business Quant data shows ENSC's Revenue at $1.37 million (Q2 2025), $1.32 million (Q1 2025) and $1.3 million (Q4 2024) in the three quarters before Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 25.31 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 16.99 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 16.61 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 14.41 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 15.38 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 10.05 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 7.80 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 15.03 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 3.33 Bn |
| 10 | Ensysce Biosciences | 1.07 Mn | -10.50 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 493,104.00 |
| Jun 30, 2025 | 1.37 Mn |
| Mar 31, 2025 | 1.32 Mn |
| Dec 31, 2024 | 1.30 Mn |
| Sep 30, 2024 | 3.42 Mn |
| Jun 30, 2024 | 181,797.00 |
| Mar 31, 2024 | 305,722.00 |
| Dec 31, 2023 | 515,032.00 |
| Sep 30, 2023 | 435,380.00 |
| Jun 30, 2023 | 490,472.00 |
| Mar 31, 2023 | 789,635.00 |
| Dec 31, 2022 | 1.43 Mn |
| Sep 30, 2022 | 279,351.00 |
| Jun 30, 2022 | 207,471.00 |
| Mar 31, 2022 | 603,098.00 |
| Dec 31, 2021 | 1.64 Mn |
| Sep 30, 2021 | 1.20 Mn |
| Jun 30, 2021 | 444,516.00 |
| Mar 31, 2021 | 250,576.00 |
| Dec 31, 2020 | 416,489.00 |
API Access
Ensysce Biosciences Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=ENSC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "ENSC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=ENSC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();